Attività Cambiamento Data
Cara Therapeutics USD 32.07M 6.95M 2025-12
Clal Biotechnology ILS 158.39M 24.3M 2023-12
Compugen USD 145.86M 10.71M 2026-03
Cronos Group USD 1.17B 25.03M 2026-03
RedHill Biopharma USD 25.34M 6.97M 2025-12